1 completed, 1 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow ISIS 304801: new trials by email Literature Review of ISIS 304801 trials Research Report on ISIS 304801
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy volanesorsen, Placebo - Familial Partial Lipodystrophy | Phase 2 / Phase 3 | Terminated | Akcea Therapeutics | 40 | 2015-12-28 | 2021-10-18 |
| Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension ISIS 304801, Placebo - Lipodystrophy | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 5 | 2015-12-23 | 2020-10-20 |
Hypertriglyceridemia (1) · Lipodystrophy (1) · Lipodystrophy, Familial Partial (1)
Akcea Therapeutics (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)
United States (2) · Belgium (1) · Brazil (1) · Canada (1) · Germany (1) · Netherlands (1) · Russia (1)
2015 (1)